VANCOUVER, BC, Dec. 7, 2021 /CNW/ - Pontus Protein Ltd. (TSXV:
HULK) (OTCQB: HLKKF) (FSE: 8YC) ("Pontus" or the
"Company") is pleased to announce that it has entered into a
consulting agreement with Sting Organics Ltd. ("Sting"), a
B.C.-based corporation farming Urtica Dioica (common name "stinging
nettles"). Sting is hiring Pontus to use stinging nettles to
develop products and market research effectively. This is the first
step in our feasibility test to help Sting produce Urtica Dioica in
a biosecure, aquaponic, automated, sustainable vertical farm
utilizing Pontus' IP.
Seva Roberts, Sting's CEO,
commented: "Stinging nettles are a leafy green vegetable that
has a long history in soups and curries. We need to develop how to
use the product and dried ingredient and research and educate the
modern population. We were attracted to the team and experience
that Pontus has amassed. I am confident working with Pontus that we
will have a range of products and recipes, plus research for our
go-to-market strategy. "
Chef Shahni, Pontus' Culinary Director, additionally
commented: "We will explore the various possibilities of
providing nettle in its fresh form and dehydrated powder that can
be used for pure nutrition and taste. With Pontus technology of
enclosed growing, we can supply the market all year round compared
to nettle being a scarce seasonal product. Stinging nettles taste
like spinach but are more nutritious than broccoli. Like Pontus'
water lentils, Sting can take their nettles and wash and dehydrate
them to create a pure, nutritious powder with 29% protein. This is
a real challenge to the highly processed pea isolates from a
nutrition and flavour point of view."
The consulting agreement includes a monthly fee to Pontus for
the services provided. This aligns with Pontus' strategy as a
technology leader to provide consulting and licencing opportunities
to leverage CEVAS and the current technology stack the company
owns. In turn, this will allow Pontus to do further research and
development on using CEVAS to grow all different types of crops and
create a branch in the company specifically to service companies
looking to use CEVAS for their operations worldwide.
Connor Yuen, Pontus' CEO, added,
"This is a huge step forward for Pontus being able to generate
revenue ahead of our start of production in early 2022."
About Pontus Protein Ltd.
Pontus Protein Ltd. is a Vancouver,
B.C. based agricultural technology company that will enable
millions to rethink their food choices while helping people do the
world a world of good. By offering sustainably grown plant based
food options that are nutritious and delicious, we're helping this
kind of diet become the norm.
Pontus is reinventing agriculture with their proprietary Closed
Environment Vertical Aquaponic System (CEVAS) – the farming of the
future. Pontus specializes in the indoor vertical farming of water
lentils that use 95% less water than traditional agriculture and no
pesticides or chemicals. Pontus is committed to solving the global
food crisis by providing access to sustainable indoor biosecure
pure plant based proteins. Pontus' water lentils can be harvested
every 24 hours, exceed organic certification, and can be grown in
any climate in a relatively small area. Our water lentil protein is
filled with antioxidants, minerals, vitamins and all the amino
acids, making a complete protein food source. Pontus aims to
revolutionize the plant based sector as the entire sector is
currently based on two main protein sources: soy and pea. Water
lentil protein is far superior to pea and soy protein. It contains
over 40% protein vs. 5-36% protein*, and Pontus aims to be the base
protein for plant based food products, leading to the movement
transitioning the world from meat based to plant based
proteins.
To learn more, please visit pontuswaterlentils.com.
*https://www.infood.net/visitor/collection/75?portion_size=100
On behalf of the Board of Directors
"Connor Yuen"
Connor Yuen, CEO
Pontus Protein Ltd.
Forward-Looking Information
Certain statements in this release are forward-looking
statements, which reflect management's expectations regarding the
Company. Forward-looking statements consist of statements that are
not purely historical, including any statements regarding beliefs,
plans, expectations or intentions regarding the future, including
but not limited to, the anticipated use of proceeds of the
Offering, Including those from the Second Tranche, by the Company
and Pontus' ability to revolutionize the plant based sector and
enable millions to rethink their food choices. Such statements are
subject to risks and uncertainties that may cause actual results,
performance or developments to differ materially from those
contained in the statements, including risks related to factors
beyond the control of the Company. These risks include, but are not
limited to, the following: the unknown magnitude and duration of
the effects of the COVID-19 pandemic, the failure of Pontus to
receive TSX Venture Exchange approval for the closing of the
remainder of the Offering, Pontus' inability to close further
tranches of the Offering, the failure of Pontus to receive the
necessary approvals from the Canadian Food Inspection Agency for
its products and facilities, the inability to complete Pontus'
Surrey Facility, as well as other general business, economic, or
market related risks beyond the director control of the Company and
which may affect the Company's business, operations, or products.
No assurance can be given that any of the events anticipated by the
forward-looking statements will occur or, if they do occur, what
benefits the Company will obtain from them. The Company undertakes
no obligation to update forward-looking information if
circumstances or management's estimates or opinions should change,
unless required by law. The reader is cautioned not to place undue
reliance on forward-looking information.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in policies
of the TSX Venture Exchange) accept responsibility for the adequacy
or accuracy of this release.
SOURCE Pontus Protein Ltd.
